These include markers of inflammation (elevated C-reactive protein (CRP)), cytotoxicity (increased lactate dehydrogenase (LDH)), and both macrovascular and microvascular thrombosis in systemic and pulmonary circulations (higher D-dimer levels), as well as lymphopenia (Figure 1) [41,42]. The gene discussed is CRP; the disease is lymphopenia.